Endocrine Abstracts

Introduction: The COVID-19 pandemic resulted in various outcomes that have altered disease prevalence and drug utilization patterns. Our study aimed to evaluate the trends in the utilization and costs of antidiabetic medications before and during the COVID-19 outbreak in Turkey.Methods: We obtained nationwide sales data for antidiabetics from IQVIA Turkey, spanning between April 2018 and March 2022. Mean monthly drug utilization and expenditure trends be...